166 related articles for article (PubMed ID: 10637718)
21. Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital.
Naas T; Fortineau N; Spicq C; Robert J; Jarlier V; Nordmann P
J Hosp Infect; 2005 Dec; 61(4):321-9. PubMed ID: 16026895
[TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VK; Rohani MY; Kamel AG
Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
[TBL] [Abstract][Full Text] [Related]
23. Nasal carriage and antibiotic susceptibility of Staphylococcus aureus in general practice.
Gillett AP; Johnson T; Orton C; Wills R; Menday AP; Talbot DJ
J R Coll Gen Pract; 1984 May; 34(262):255-7. PubMed ID: 6737360
[TBL] [Abstract][Full Text] [Related]
24. Glycopeptide and oxacillin activity against Staphylococcus aureus isolates at a tertiary care center in Lebanon.
Kanj SS; Ghaleb PA; Araj GF
J Med Liban; 2004; 52(1):8-12. PubMed ID: 15881695
[TBL] [Abstract][Full Text] [Related]
25. Unusual form of oxacillin resistance in methicillin-resistant Staphylococcus aureus clinical strains.
Forbes BA; Bombicino K; Plata K; Cuirolo A; Webber D; Bender CL; Rosato AE
Diagn Microbiol Infect Dis; 2008 Aug; 61(4):387-95. PubMed ID: 18508224
[TBL] [Abstract][Full Text] [Related]
26. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis.
McLaws F; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
29. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
Sharma V; Sharma S; Garg P; Rao GN
Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
[TBL] [Abstract][Full Text] [Related]
30. [Comparative experimental study of ceporin and oxacillin].
Zhukov VG; Navashin SM
Antibiotiki; 1970 Feb; 15(2):120-3. PubMed ID: 4910122
[No Abstract] [Full Text] [Related]
31. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities.
Niebuhr M; Mai U; Kapp A; Werfel T
Exp Dermatol; 2008 Nov; 17(11):953-7. PubMed ID: 18557929
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
Anwar MS; Bokhari SR
J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
[TBL] [Abstract][Full Text] [Related]
33. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
Koning S; Thomas S; van der Wouden JC
Ned Tijdschr Geneeskd; 2003 Jan; 147(3):134; author reply 135. PubMed ID: 12577775
[No Abstract] [Full Text] [Related]
34. Clonal spread of Staphylococcus aureus with reduced susceptibility to oxacillin in a dermatological hospital unit.
Thomsen MK; Rasmussen M; Fuursted K; Westh H; Pedersen LN; Deleuran M; Møller JK
Acta Derm Venereol; 2006; 86(3):230-4. PubMed ID: 16710581
[TBL] [Abstract][Full Text] [Related]
35. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
36. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of oxacillin-resistant Staphylococcus aureus in Brooklyn, New York.
Landman D; Bratu S; Flores C; Sathe S; Maccario E; Ravishankar J; Quale J
Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):58-61. PubMed ID: 12582747
[TBL] [Abstract][Full Text] [Related]
38. Phage pattern-specific oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus in U.S. hospitals: epidemiological significance.
Zierdt CH; Hosein IK; Shively R; MacLowry JD
J Clin Microbiol; 1992 Jan; 30(1):252-4. PubMed ID: 1734064
[TBL] [Abstract][Full Text] [Related]
39. A novel fusidic acid resistance determinant, fusF, in Staphylococcus cohnii.
Chen HJ; Hung WC; Lin YT; Tsai JC; Chiu HC; Hsueh PR; Teng LJ
J Antimicrob Chemother; 2015 Feb; 70(2):416-9. PubMed ID: 25313205
[TBL] [Abstract][Full Text] [Related]
40. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid.
Huebner J; Kropec A; Engels I; Daschner F
Chemotherapy; 1992; 38(4):206-10. PubMed ID: 1473358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
